Aligeydar A. Ragimov

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Colorectal cancer (CRC) is the third most common malignancy in industrialized countries. Despite the advances in diagnostics and development of new drugs, the 5-year survival remains only 60-65%. Our approach to early diagnostics of CRC is based on the determination of serological signatures with an array of hemispherical hydrogel cells containing(More)
  • 1